(Q44314293)

English

Effect of melatonin on changes in locomotor activity rhythm of Syrian hamsters injected with beta amyloid peptide 25-35 in the suprachiasmatic nuclei

scientific article published in December 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Effect of melatonin on changes in locomotor activity rhythm of Syrian hamsters injected with beta amyloid peptide 25-35 in the suprachiasmatic nuclei (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

0 references

Santiago Perez-Lloret

4

object named as

Santiago Pérez Lloret

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

Analía M Furio

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Rodolfo A Cutrera

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Víctor Castillo Thea

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Patricia Riccio

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Roberto L Caccuri

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Luis L Brusco

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Daniel P Cardinali

8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

1 December 2002

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Cellular and Molecular Neurobiology

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

5-6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

699-709

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

https://scigraph.springernature.com/pub.10.1023/a:1021805023906

0 references

Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chrono-neuroendocrinological aspects of physiological aging and senile dementia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ca2+ channel blockers attenuate beta-amyloid peptide toxicity to cortical neurons in culture.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment and Management of "Sundowning" Phenomena

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circadian rhythm-related behavioral disturbances and structural hypothalamic changes in Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Basic aspects of melatonin action.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of melatonin in two individuals with Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degeneration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double blind-placebo controlled study on melatonin efficacy to reduce anxiolytic benzodiazepine use in the elderly

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monozygotic twins with Alzheimer's disease treated with melatonin: Case report.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Melatonin treatment stabilizes chronobiologic and cognitive symptoms in Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of sleep disturbance in Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxidative stress in Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The protective effects of melatonin from oxidative damage induced by amyloid beta-peptide 25-35 in middle-aged rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Melatonin as a pharmacological agent against neuronal loss in experimental models of Huntington's disease, Alzheimer's disease and parkinsonism

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Melatonin for treatment of sundowning in elderly persons with dementia - a preliminary study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A critical assessment of the melatonin effect on sleep in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amnestic effects in mice of four synthetic peptides homologous to amyloid beta protein from patients with Alzheimer disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age-dependent reduction in serum melatonin concentrations in healthy human subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemistry and biochemistry of oxidative stress in neurodegenerative disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low urinary 6-sulphatoxymelatonin levels in patients with coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diminished melatonin secretion in the elderly caused by insufficient environmental illumination

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

beta-Amyloid protein-induced Alzheimer's disease animal model.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amyloid beta-peptide is produced by cultured cells during normal metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Supplementary administration of artificial bright light and melatonin as potent treatment for disorganized circadian rest-activity and dysfunctional autonomic and neuroendocrine systems in institutionalized demented elderly persons

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased melatonin 1a-receptor immunoreactivity in the hippocampus of Alzheimer's disease patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The molecular pathology of Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High melatonin concentrations in third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of changes in serum prolactin, FSH, TSH, and estradiol after melatonin treatment in doses that improve sleep and reduce benzodiazepine consumption in sleep-disturbed, middle-aged, and elderly patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered circadian cortisol secretion in Alzheimer's disease: clinical and neuroradiological aspects

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Actigraphic sleep-wake patterns and urinary 6-sulfatoxymelatonin excretion in patients with Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circadian rhythms and sleep in human aging

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apoptosis is induced by beta-amyloid in cultured central nervous system neurons

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/12585689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1021805023906

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44314293&oldid=2151552935"